|
1. Taking Control of MS
|
|
| What is Multiple Sclerosis? Multiple Sclerosis is a serious neurological disease characterized by a wide variety of impairments that often become progressively worse with time. Sadly many people with MS eventually become confined to a wheelchair because they have not been able to significantly slow or halt disease progression MS is classified as an autoimmune disease. The basic disease process of an autoimmune disease such as MS is that a person’s own immune system attacks specific parts of the body. |
 |
|
2. Protect Your Family from MS
|
|
Preventing Multiple Sclerosis
One of the greatest fears of those with multiple sclerosis is that one or more of their children will also get MS and such a fear is not unrealistic. First-degree relatives (children, siblings) of persons with MS have a much greater risk of contracting MS than the general population has. Thus it seems reasonable to expect that the topic of Prevention of Multiple Sclerosis would be a very important one for MS researchers, neurologists and MS societies.
|
 |
|
3. MS - The Alberta Disadvantage
|
|
| The purpose of this booklet is to explain why MS is so common in Alberta and to describe how Albertans can greatly lower their risk of MS. It also challenges the provincial government to become proactive and to take the necessary actions needed to eliminate this major Alberta Disadvantage. |
 |
|
Article 1 - First Do No Harm
|
|
| Most MS researchers are doctors (MDs) rather than formally trained scientists (PhDs). Doctors claim to follow the laudatory and common sense goal of “First Do No Harm”. For the MS researchers this oath translates to “First Do Research that Leads to Therapies that Do No Harm” and our main question is whether or not MS researchers come remotely close to following this maxim.
The widely accepted autoimmune model of the MS disease process guides the MS research effort. In brief, this model appeals to foreign proteins to activate myelin-sensitive T cells that then cross the blood-brain barrier and initiate an immune attack on myelin proteins in the central nervous system.
|
|
Article 2 - MS and Vitamin D Deficiency
|
|
|
Recently a team of researchers from Canada and Britain led by Dr George Ebers of Oxford University published an important paper which provided evidence that persons born in the spring and early summer (April to July) were more likely to contract MS than those born in late fall and early winter (October to January).
|
|
Article 3 - MS and Vitamin D Supplementation
|
|
| |
